Prefilled Syringes Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

Prefilled Syringes Market by Material Type (Plastic Prefilled Syringes, Glass Prefilled Syringes, by Prefilled Syringes Type (Conventional Prefilled Syringes, Safety Prefilled Syringes), by Design (Single Chamber PFS, Dual-chamber PFS, Customized PFS), by End Users (Pharmaceutical Companies, Biopharmaceutical Companies, Drug Discovery & Research Organizations, Others) and Geography.

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global prefilled syringes market size was valued US$ 4781 million in 2020 and projected to reach US$ 7916 million by 2026 at CAGR 9%. Traditional prefilled syringes and safety prefilled syringes are the two primary types of prefilled syringes. Prefilled syringes often contain a single-dose package of vaccination with a needle pre-installed by the manufacturer. The needle is only used once, and the syringe is discarded after usage. Patients who require regular injections at home can use safety prefilled syringes to self-administer a single-dose package of vaccination. Single-chamber prefilled syringes, dual-chamber prefilled syringes, and customised prefilled syringes are among the syringes made of glass and plastic. In addition, the report includes new product introduction, regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Increasing adoption prefilled syringes format for parenteral drug administration, rising biologic product approvals, increased product availability in PFS format for home-based healthcare, and safety associated with prefilled syringes driving market revenue growth of the market over the forecast period. Moreover, inherited benefits such as dose accuracy, convenience in usage, sterility and advantages over conventional drug delivery are the factors driving the market revenue growth. Pharmaceutical and biopharmaceutical companies yet to exploit the full potential of prefilled syringes formats for drug administration and this non-adoption of PFS formats can be attributed to the availability of other alternative drug administration methods. In addition, lower penetration of PFS in developing economies hindering market revenues growth over the forecast period. Currently, the majority of PFS are designed to compatible with biologic drugs than non-biologic drugs.

 

 

 


Prefilled Syringes Market

MARKET SUMMARY
-
9%
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 9%
  • Largest Market– Europe
  • Fastest Growing Market– Asia-Pacific

Prefilled Syringes Market Report

  • The report gives historical, current, and future market sizes (US$ Mn) on the basis of material type, prefilled syringes type, design, end user, and geographic regions.
  • The prefilled syringes market report gives a comprehensive outlook on prefilled syringes across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA).
  • This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market.
  • Key stakeholders of the market report include suppliers, manufacturers, marketers, policymakers engaged in manufacturing and supply of prefilled syringes.

 

Key Players
  • Becton, Dickinson and Company (U.S.)
  • Catalent, Inc. (U.S.)
  • Gerresheimer (Germany)
  • Haselmeier (Switzerland)
  • MedPro Inc. (U.S.)
  • Nipro Corporation (Japan)
Drivers and Restrains

Prefilled Syringes Market

Prefilled syringes are mostly used to treat chronic ailments that require patients to self-administer drugs, such as heart disease, diabetes, and autoimmune diseases. As a result, the rising incidence and prevalence of chronic and lifestyle diseases around the world is a primary factor driving the prefilled syringes market. Prefilled syringes improve patient safety by lowering the risk of unintended needle sticking and harmful product exposure that can occur while drawing medication from vials. However, when compared to syringes with integrated safety devices, the usage of naked prefilled syringes is associated with a high frequency of needle stick injuries.


Europe got significant share

Prefilled Syringes Market

Europe expected to lead the global prefilled syringes industry in terms of revenue in over the forecast period. Regions such as Asia Pacific and North America presented better growth opportunities for the market players owing to rise in prevalence of chronic diseases and availability of large untapped market.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2015-2020) and forecast (2021-2026)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Key

Key Findings of the Report

Prefilled Syringes Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Becton, Dickinson and Company (U.S.)
  • Catalent, Inc. (U.S.)
  • Gerresheimer (Germany)
  • Haselmeier (Switzerland)
  • MedPro Inc. (U.S.)
  • Nipro Corporation (Japan)
  • Ompi (Italy)
  • Owen Mumford (UK)
  • SCHOTT AG (Germany)
  • Terumo Medical Corporation (Japan)
  • Unilife Corporation (U.S.)
  • Vetter Pharma International GmbH (Germany)
  • Weigao Group (China)
  • West Pharmaceutical Services, Inc. (U.S.)
  • Ypsomed Holding AG (Switzerland)

Description

The global prefilled syringes market size was valued US$ 4781 million in 2020 and projected to reach US$ 7916 million by 2026 at CAGR 9%. Traditional prefilled syringes and safety prefilled syringes are the two primary types of prefilled syringes. Prefilled syringes often contain a single-dose package of vaccination with a needle pre-installed by the manufacturer. The needle is only used once, and the syringe is discarded after usage. Patients who require regular injections at home can use safety prefilled syringes to self-administer a single-dose package of vaccination. Single-chamber prefilled syringes, dual-chamber prefilled syringes, and customised prefilled syringes are among the syringes made of glass and plastic. In addition, the report includes new product introduction, regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Increasing adoption prefilled syringes format for parenteral drug administration, rising biologic product approvals, increased product availability in PFS format for home-based healthcare, and safety associated with prefilled syringes driving market revenue growth of the market over the forecast period. Moreover, inherited benefits such as dose accuracy, convenience in usage, sterility and advantages over conventional drug delivery are the factors driving the market revenue growth. Pharmaceutical and biopharmaceutical companies yet to exploit the full potential of prefilled syringes formats for drug administration and this non-adoption of PFS formats can be attributed to the availability of other alternative drug administration methods. In addition, lower penetration of PFS in developing economies hindering market revenues growth over the forecast period. Currently, the majority of PFS are designed to compatible with biologic drugs than non-biologic drugs.

 

 

 

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX